Facilitated By

San Antonio Medical Foundation

Monoclonal Antiboty Neutralization assay SARS-CoV-2 (Regeneron nonfederal in vitro assays)

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Funded by
Regeneron Pharmaceuticals, Inc.
Research Start Date
Status
Active

The purpose of this project is to test monoclonal antibodies in a neutralization assay with SARS-CoV-2 virus to generate IC50 values.

Collaborative Project
Drug Discovery
Infectious Disease